Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q4 FY24 results · Jan–Mar 2024
Unichem Laboratories reported revenue from operations of ₹431.70 crore (up 7.4% from Q4 FY23) and net loss of ₹129.31 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 431.70 | 402.10 | +7.4% | 434.38 | −0.6% |
| Other income | 6.15 | 5.11 | +20.4% | 11.28 | −45.4% |
| Total income | 437.85 | 407.21 | +7.5% | 445.66 | −1.8% |
| Profit before tax | (125.87) | (47.16) | Loss widened | 83.97 | Turned loss |
| Net profit for the period | (129.31) | (44.27) | Loss widened | 83.99 | Turned loss |
| EPS, basic (₹) | (18.37) | (6.28) | Loss widened | 11.93 | Turned loss |
| Net margin (%) | -30.0 | -11.0 | 19.3 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 399.24 | 310.06 | +28.8% | 362.43 | +10.2% |
| Other income | 7.04 | 3.79 | +85.8% | 9.94 | −29.2% |
| Total income | 406.28 | 313.85 | +29.4% | 372.37 | +9.1% |
| Profit before tax | (114.97) | (143.83) | Loss narrowed | 69.30 | Turned loss |
| Net profit for the period | (114.97) | (143.83) | Loss narrowed | 69.30 | Turned loss |
| EPS, basic (₹) | (16.33) | (20.43) | Loss narrowed | 9.85 | Turned loss |
| Net margin (%) | -28.8 | -46.4 | 19.1 |
Consolidated
- Filed with BSE
- 23 May 2024, 10:57 IST
- Board meeting
- 22 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 23 May 2024, 10:57 IST
- Board meeting
- 22 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE